Linked Life Data

20967251

Source:http://linkedlifedata.com/resource/pubmed/id/20967251

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-10-22
pubmed:abstractText
Molecular studies have demonstrated that mutations in the Plasmodium falciparum chloroquine resistance transporter gene (Pfcrt) play a major role in chloroquine resistance, while mutations in P. falciparum multidrug resistance gene (Pfmdr-1) act as modulator. In Madagascar, the high rate of chloroquine treatment failure (44%) appears disconnected from the overall level of in vitro CQ susceptibility (prevalence of CQ-resistant parasites <5%) or Pfcrt mutant isolates (<1%), strongly contrasting with sub-Saharan African countries. Previous studies showed a high frequency of Pfmdr-1 mutant parasites (>60% of isolates), but did not explore their association with P. falciparum chloroquine resistance. To document the association of Pfmdr-1 alleles with chloroquine resistance in Madagascar, 249 P. falciparum samples collected from patients enrolled in a chloroquine in vivo efficacy study were genotyped in Pfcrt/Pfmdr-1 genes as well as the estimation of the Pfmdr-1 copy number. Except 2 isolates, all samples displayed a wild-type Pfcrt allele without Pfmdr-1 amplification. Chloroquine treatment failures were significantly associated with Pfmdr-1 86Y mutant codon (OR?=?4.6). The cumulative incidence of recurrence of patients carrying the Pfmdr-1 86Y mutation at day 0 (21 days) was shorter than patients carrying Pfmdr-1 86N wild type codon (28 days). In an independent set of 90 selected isolates, in vitro susceptibility to chloroquine was not associated with Pfmdr-1 polymorphisms. Analysis of two microsatellites flanking Pfmdr-1 allele showed that mutations occurred on multiple genetic backgrounds. In Madagascar, Pfmdr-1 polymorphism is associated with late chloroquine clinical failures and unrelated with in vitro susceptibility or Pfcrt genotype. These results highlight the limits of the current in vitro tests routinely used to monitor CQ drug resistance in this unique context. Gaining insight about the mechanisms that regulate polymorphism in Pfmdr1 remains important, particularly regarding the evolution and spread of Pfmdr-1 alleles in P. falciparum populations under changing drug pressure which may have important consequences in terms of antimalarial use management.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e13281
pubmed:meshHeading
pubmed-meshheading:20967251-ATP-Binding Cassette Transporters, pubmed-meshheading:20967251-Alleles, pubmed-meshheading:20967251-Animals, pubmed-meshheading:20967251-Antimalarials, pubmed-meshheading:20967251-Chloroquine, pubmed-meshheading:20967251-DNA, Protozoan, pubmed-meshheading:20967251-Drug Resistance, pubmed-meshheading:20967251-Gene Dosage, pubmed-meshheading:20967251-Madagascar, pubmed-meshheading:20967251-Malaria, Falciparum, pubmed-meshheading:20967251-Membrane Transport Proteins, pubmed-meshheading:20967251-Microsatellite Repeats, pubmed-meshheading:20967251-Plasmodium falciparum, pubmed-meshheading:20967251-Polymorphism, Genetic, pubmed-meshheading:20967251-Prospective Studies, pubmed-meshheading:20967251-Protozoan Proteins, pubmed-meshheading:20967251-Rats, pubmed-meshheading:20967251-Risk Factors
pubmed:year
2010
pubmed:articleTitle
Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar.
pubmed:affiliation
Institut Pasteur, Antananarivo, Madagascar.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study